GeneDx Holdings Corp. ( WGS) - Key Metrics
WGS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.85 | -$0.60 | -$0.98 | -$1.32 |
| 2026Q1 | $3.49 | -$2.16 | -$1.10 | -$1.32 |
| 2025Q4 | $4.50 | -$0.66 | -$0.11 | -$0.28 |
| 2025Q3 | $4.05 | -$0.27 | $0.55 | $0.33 |
| 2025Q2 | $3.59 | $0.38 | $0.36 | $0.28 |
WGS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -28.60 |
| 2026Q1 | 0% | -7.43 |
| 2025Q4 | 0% | -53.30 |
| 2025Q3 | 0% | -99.76 |
| 2025Q2 | 0% | 60.73 |
WGS
Price: $85.99
52 week price:
Earnings Per Share: -3.63 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Market Capitalization: 2.6 billion